|
|
Salvage Therapy Post Pomalidomide-Based Regimen in Relapsed/Refractory Myeloma
Guillemette Fouquet
,
Lionel Karlin
,
Margaret Macro
,
Denis Caillot
,
Murielle Roussel
et al.
Blood, 2015, 126 (23), pp.1831
Journal articles
hal-01300804v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Cell-of-Origin (COO) Classification, BCL2 and MYC Expression Associated Outcome in Younger Patients Treated By RCHOP Front-Line Therapy Versus Intensive Regimen Followed By Autologous Transplant for De Novo Advanced Diffuse Large B Cell Lymphoma (DLBCL) : Results of the French Prospective Multicenter Randomized Trial Goelams-075
Gaëlle Laboure
,
Marie-Cecile Parrens
,
Anjarasoa Tsaranazy
,
Magali Bordier
,
Steven Le Gouill
et al.
55th Annual Meeting and Exposition of the American-Society-of-Hematology, Dec 2013, La Nouvelle Orléans, United States. 126 (23), pp.3920, 2015
Conference poster
hal-01290432v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
R-CHOP 14 with or without radiotherapy in non-bulky limited-stage diffuse large B-cell lymphoma (DLBCL)
Thierry Lamy
,
Gandhi Damaj
,
Pierre Soubeyran
,
Emmanuel Gyan
,
Guillaume Cartron
et al.
Journal articles
hal-01635792v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Addition of Lomustine (CCNU) to Induction and Post-Remission Chemotherapy for Fit Elderly AML Patients without Unfavorable Cytogenetics: Results of the Lamsa-2007 Goelams Trial
Arnaud Pigneux
,
Christian Récher
,
Marie C. Bene
,
Julien Asselineau
,
Ariane C. Mineur
et al.
Blood, 2015, 126 (23)
Journal articles
hal-01295674v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|